BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31817042)

  • 1. Direct Targeting Options for STAT3 and STAT5 in Cancer.
    Orlova A; Wagner C; de Araujo ED; Bajusz D; Neubauer HA; Herling M; Gunning PT; Keserű GM; Moriggl R
    Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.
    de Araujo ED; Orlova A; Neubauer HA; Bajusz D; Seo HS; Dhe-Paganon S; Keserű GM; Moriggl R; Gunning PT
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31717342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer.
    Wingelhofer B; Neubauer HA; Valent P; Han X; Constantinescu SN; Gunning PT; Müller M; Moriggl R
    Leukemia; 2018 Aug; 32(8):1713-1726. PubMed ID: 29728695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.
    Rajala HL; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
    Ann Med; 2014 May; 46(3):114-22. PubMed ID: 24512550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.
    Brachet-Botineau M; Polomski M; Neubauer HA; Juen L; Hédou D; Viaud-Massuard MC; Prié G; Gouilleux F
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the signal transducer and activator of transcription family of genes in cancer.
    Shahmarvand N; Nagy A; Shahryari J; Ohgami RS
    Cancer Sci; 2018 Apr; 109(4):926-933. PubMed ID: 29417693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.
    Page BD; Khoury H; Laister RC; Fletcher S; Vellozo M; Manzoli A; Yue P; Turkson J; Minden MD; Gunning PT
    J Med Chem; 2012 Feb; 55(3):1047-55. PubMed ID: 22148584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.
    Clarkson RW; Boland MP; Kritikou EA; Lee JM; Freeman TC; Tiffen PG; Watson CJ
    Mol Endocrinol; 2006 Mar; 20(3):675-85. PubMed ID: 16293640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
    Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
    J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic STAT3 mutations in large granular lymphocytic leukemia.
    Koskela HL; Eldfors S; Ellonen P; van Adrichem AJ; Kuusanmäki H; Andersson EI; Lagström S; Clemente MJ; Olson T; Jalkanen SE; Majumder MM; Almusa H; Edgren H; Lepistö M; Mattila P; Guinta K; Koistinen P; Kuittinen T; Penttinen K; Parsons A; Knowles J; Saarela J; Wennerberg K; Kallioniemi O; Porkka K; Loughran TP; Heckman CA; Maciejewski JP; Mustjoki S
    N Engl J Med; 2012 May; 366(20):1905-13. PubMed ID: 22591296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.
    Rajala HL; Eldfors S; Kuusanmäki H; van Adrichem AJ; Olson T; Lagström S; Andersson EI; Jerez A; Clemente MJ; Yan Y; Zhang D; Awwad A; Ellonen P; Kallioniemi O; Wennerberg K; Porkka K; Maciejewski JP; Loughran TP; Heckman C; Mustjoki S
    Blood; 2013 May; 121(22):4541-50. PubMed ID: 23596048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-inhibitors of STAT5 and STAT3: studies from molecular docking and molecular dynamics simulations.
    Shao S; Yu R; Yu Y; Li Y
    J Mol Model; 2014 Aug; 20(8):2399. PubMed ID: 25098340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis.
    Gorodetskiy VR; Sidorova YV; Kupryshina NA; Vasilyev VI; Probatova NA; Ryzhikova NV; Sudarikov AB
    Rheumatol Int; 2021 Jan; 41(1):147-156. PubMed ID: 33280072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.
    Spiekermann K; Pau M; Schwab R; Schmieja K; Franzrahe S; Hiddemann W
    Exp Hematol; 2002 Mar; 30(3):262-71. PubMed ID: 11882364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptotanshinone suppresses key onco-proliferative and drug-resistant pathways of chronic myeloid leukemia by targeting STAT5 and STAT3 phosphorylation.
    Dong B; Liang Z; Chen Z; Li B; Zheng L; Yang J; Zhou H; Qu L
    Sci China Life Sci; 2018 Sep; 61(9):999-1009. PubMed ID: 30054832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
    Dong S; Tweardy DJ
    Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
    Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP
    PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops.
    von Manstein V; Yang CM; Richter D; Delis N; Vafaizadeh V; Groner B
    Curr Signal Transduct Ther; 2013 Dec; 8(3):193-202. PubMed ID: 25045345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel multiplexed assay for identifying SH2 domain antagonists of STAT family proteins.
    Takakuma K; Ogo N; Uehara Y; Takahashi S; Miyoshi N; Asai A
    PLoS One; 2013; 8(8):e71646. PubMed ID: 23977103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation.
    Wang W; Lopez McDonald MC; Hariprasad R; Hamilton T; Frank DA
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.